Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transplants in AML.

R P Gale1, A Butturini

  • 1Department of Medicine, UCLA School of Medicine 90024.

Bone Marrow Transplantation
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Comparing acute myelogenous leukemia (AML) treatments like bone marrow transplants and chemotherapy is complex. Current evidence suggests treatment results are not significantly different, hindering a clear consensus on the best approach for AML patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential Habitability of Present-Day Martian Subsurface for Earth-Like Methanogens.

Astrobiology·2025
Same author

Origin, accumulation and fate of dissolved organic matter in an extreme hypersaline shallow lake.

Water research·2022
Same author

Dissolved organic matter in a tropical saline-alkaline lake of the East African Rift Valley.

Water research·2020
Same author

Can Long-Term Bone Marrow Culture Eliminate Leukemia Cells?

Leukemia & lymphoma·2016
Same author

Hydrological conditions control in situ DOM retention and release along a Mediterranean river.

Water research·2016
Same author

The effects of sediment depth and oxygen concentration on the use of organic matter: An experimental study using an infiltration sediment tank.

The Science of the total environment·2015
Same journal

Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

Bone marrow transplantation·2026
Same journal

Impact of doublet post-transplant maintenance on outcomes in multiple myeloma: A propensity score matching analysis.

Bone marrow transplantation·2026
Same journal

A multimodal sexual health intervention among hematopoietic stem cell transplant recipients: mediating effects on quality of life and mood.

Bone marrow transplantation·2026
Same journal

Excellent clinical and patient-reported outcomes following matched sibling donor BMT for sickle cell disease.

Bone marrow transplantation·2026
Same journal

The risk of anxiety and depression in Swedish potential stem cell donors-need for increased psychological evaluation and support?

Bone marrow transplantation·2026
Same journal

False-positive HIV-1 RNA detection following obecabtagene autoleucel.

Bone marrow transplantation·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Clinical Trials

Background:

  • Acute myelogenous leukemia (AML) treatment involves allogeneic bone marrow transplants, autotransplants, and chemotherapy.
  • The optimal treatment strategy for AML remains a subject of debate and controversy.
  • Existing research comparing these therapies faces challenges in data interpretation and applicability.

Purpose of the Study:

  • To analyze and compare the effectiveness of different acute myelogenous leukemia (AML) therapies.
  • To address the complexities and controversies in comparing treatment outcomes for AML.
  • To evaluate the limitations of current research methodologies in determining the best AML treatment.

Main Methods:

  • Review of published data from various sources, including observational databases and randomized trials.

Related Experiment Videos

  • Analysis of potential biases in reporting and subject selection in comparative studies.
  • Assessment of statistical adjustment methods used in observational studies and their validity.

    • Main Results:

    • Comparisons of published data are often flawed by biased reporting and subject selection.
    • Randomized trials have limitations such as small sample sizes and questionable generalizability.
    • Complex statistical adjustments in observational studies are necessary but their validity is debated.

    Conclusions:

    • A precise, universally accepted answer on the best AML treatment is unlikely due to methodological limitations and data complexities.
    • Subjectivity in physician decision-making further complicates the development of a treatment consensus.
    • The lack of significant differences in outcomes across diverse AML treatments may impede consensus formation.